An Open-label Study of Povetacicept in Autoantibody-Associated Glomerular Diseases

Investigational Site (519), Concord

Investigational Site (515), Saint Albans

Investigational Site (102), Nedlands

Investigational Site (504), Goyang-si

Investigational Site (508), Brooklyn

Investigational Site (510), Guri-si

Investigational Site (511), Albany

Investigational Site (505), Anyang-si

Investigational Site (116), Suwon

Investigational Site (518), Bethlehem

The Johns Hopkins University School of Medicine, Baltimore

Investigational Site (502), Lawrenceville

Investigational Site (507), Cheonan

Investigational Site (512), Orlando

Investigational Site (525), Tamarac

Washington University School of Medicine in St. Louis, St Louis

Investigational Site (526), Irving

Investigational Site (118), Colleyville

Investigational Site (516), Houston

Investigational Site (513), Arvada

Investigational Site (523), Phoenix

Investigational Site (501), Phoenix

Investigational Site (524), Tucson

Investigational Site (506), Valencia

Investigational Site (503), Boston

Investigational Site (509), Newark

Investigational Site (191), Caguas

Investigational Site (125), Seoul

Investigational Site (520), Seoul

Investigational Site (521), Seoul